Jiangsu Hengrui Medicine Co., Ltd. (SHA:600276)
China
· Delayed Price · Currency is CNY 46.49
+1.46 (3.24%)
Mar 14, 2025, 2:44 PM CST
Jiangsu Hengrui Medicine Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 13, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 295,927 | 287,598 | 245,741 | 323,076 | 591,745 | 385,431 | Upgrade
|
| Market Cap Growth | 16.38% | 17.03% | -23.94% | -45.40% | 53.53% | 98.44% | Upgrade
|
| Enterprise Value | 273,673 | 270,642 | 228,393 | 306,010 | 576,180 | 372,593 | Upgrade
|
| Last Close Price | 46.54 | 45.01 | 38.21 | 50.09 | 91.52 | 59.75 | Upgrade
|
| PE Ratio | 54.13 | 66.85 | 62.91 | 71.32 | 93.51 | 72.34 | Upgrade
|
| Forward PE | 51.71 | 56.94 | 49.45 | 52.14 | 85.65 | 72.09 | Upgrade
|
| PS Ratio | 11.34 | 12.60 | 11.55 | 12.47 | 21.34 | 16.55 | Upgrade
|
| PB Ratio | 6.67 | 7.01 | 6.40 | 9.08 | 19.22 | 15.46 | Upgrade
|
| P/TBV Ratio | 7.81 | 7.27 | 6.59 | 9.35 | 19.62 | 15.78 | Upgrade
|
| P/FCF Ratio | 47.11 | 46.69 | - | 126.49 | 205.64 | 118.39 | Upgrade
|
| P/OCF Ratio | 41.99 | 37.63 | 194.22 | 76.58 | 172.42 | 100.98 | Upgrade
|
| PEG Ratio | 4.04 | 3.47 | 10.27 | 4.78 | 3.53 | 3.30 | Upgrade
|
| EV/Sales Ratio | 10.53 | 11.86 | 10.74 | 11.81 | 20.77 | 16.00 | Upgrade
|
| EV/EBITDA Ratio | 43.87 | 56.03 | 63.46 | 71.83 | 85.74 | 60.88 | Upgrade
|
| EV/EBIT Ratio | 50.14 | 64.81 | 74.65 | 81.29 | 91.87 | 67.73 | Upgrade
|
| EV/FCF Ratio | 43.56 | 43.94 | - | 119.81 | 200.23 | 114.45 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.04 | 0.00 | - | - | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.02 | 0.37 | 0.04 | - | - | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.01 | - | 0.06 | - | - | Upgrade
|
| Asset Turnover | 0.57 | 0.53 | 0.52 | 0.70 | 0.89 | 0.93 | Upgrade
|
| Inventory Turnover | 1.49 | 1.50 | 1.44 | 1.80 | 1.98 | 2.21 | Upgrade
|
| Quick Ratio | 7.79 | 10.74 | 7.36 | 7.72 | 6.70 | 8.08 | Upgrade
|
| Current Ratio | 9.00 | 12.25 | 8.50 | 8.87 | 7.44 | 9.02 | Upgrade
|
| Return on Equity (ROE) | 12.88% | 10.77% | 10.31% | 13.51% | 22.64% | 23.81% | Upgrade
|
| Return on Assets (ROA) | 7.48% | 6.06% | 4.68% | 6.36% | 12.59% | 13.78% | Upgrade
|
| Return on Capital (ROIC) | 8.05% | 6.45% | 5.07% | 7.08% | 14.07% | 15.37% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.26% | 10.13% | 7.90% | 10.50% | 20.26% | 21.93% | Upgrade
|
| Earnings Yield | 1.84% | 1.50% | 1.59% | 1.40% | 1.07% | 1.38% | Upgrade
|
| FCF Yield | 2.12% | 2.14% | -0.30% | 0.79% | 0.49% | 0.84% | Upgrade
|
| Dividend Yield | 0.44% | 0.44% | 0.42% | 0.32% | 0.18% | 0.27% | Upgrade
|
| Payout Ratio | 23.40% | 23.77% | 26.00% | 23.54% | 16.07% | 15.22% | Upgrade
|
| Buyback Yield / Dilution | 0.70% | 1.20% | -0.37% | 0.18% | 0.02% | -0.48% | Upgrade
|
| Total Shareholder Return | 1.14% | 1.64% | 0.05% | 0.50% | 0.21% | -0.21% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.